These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 23807364)

  • 1. Acute immune thrombocytopenic purpura as adverse reaction to oral polio vaccine (OPV).
    Jin CQ; Dong HX; Sun ZX; Zhou JW; Dou CY; Lu SH; Yang RR
    Hum Vaccin Immunother; 2013 Aug; 9(8):1739-40. PubMed ID: 23807364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acute thrombocytopenic purpura following rubella vaccination].
    Yamamoto T; Kino T; Yagi K; Miyata H; Yoshioka K
    Rinsho Ketsueki; 1996 Nov; 37(11):1328-30. PubMed ID: 8960672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis.
    Ciapponi A; Bardach A; Rey Ares L; Glujovsky D; Cafferata ML; Cesaroni S; Bhatti A
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011260. PubMed ID: 31801180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune Thrombocytopenia Following Diphtheria Pertussis- Tetanus and Oral Polio Vaccine.
    Bhowmik A; Biswas T
    Indian Pediatr; 2016 Oct; 53(10):934-935. PubMed ID: 27771689
    [No Abstract]   [Full Text] [Related]  

  • 5. Surveillance for poliovirus vaccine adverse events, 1991 to 1998: impact of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine.
    Wattigney WA; Mootrey GT; Braun MM; Chen RT
    Pediatrics; 2001 May; 107(5):E83. PubMed ID: 11331733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombocytopenic purpura as adverse reaction to recombinant hepatitis B vaccine.
    Ronchi F; Cecchi P; Falcioni F; Marsciani A; Minak G; Muratori G; Tazzari PL; Beverini S
    Arch Dis Child; 1998 Mar; 78(3):273-4. PubMed ID: 9613364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine poliovirus shedding and immune response to oral polio vaccine in HIV-infected and -uninfected Zimbabwean infants.
    Troy SB; Musingwini G; Halpern MS; Huang C; Stranix-Chibanda L; Kouiavskaia D; Shetty AK; Chumakov K; Nathoo K; Maldonado YA
    J Infect Dis; 2013 Aug; 208(4):672-8. PubMed ID: 23661792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trials.
    De Coster I; Leroux-Roels I; Bandyopadhyay AS; Gast C; Withanage K; Steenackers K; De Smedt P; Aerssens A; Leroux-Roels G; Oberste MS; Konopka-Anstadt JL; Weldon WC; Fix A; Konz J; Wahid R; Modlin J; Clemens R; Costa Clemens SA; Bachtiar NS; Van Damme P
    Lancet; 2021 Jan; 397(10268):39-50. PubMed ID: 33308429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polio endgame: the global introduction of inactivated polio vaccine.
    Patel M; Zipursky S; Orenstein W; Garon J; Zaffran M
    Expert Rev Vaccines; 2015 May; 14(5):749-62. PubMed ID: 25597843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-Transfusion Purpura Mimicking Idiopathic Thrombocytopenic Purpura: A Case Report.
    Milito C; Masel D; Henrichs K; Schmidt AE; Kirkley S; Aljitawi O; Becker M; Blumberg N; Refaai MA
    Lab Med; 2019 Oct; 50(4):396-400. PubMed ID: 30915450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pitfalls in the diagnosis of immune thrombocytopenic purpura in children: 4 case reports.
    Biner B; Devecioğlu O; Demir M
    Clin Appl Thromb Hemost; 2007 Jul; 13(3):329-33. PubMed ID: 17636197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal Immune Responses to Type 2 Oral Polio Vaccine (OPV) Challenge in Infants Previously Immunized With Bivalent OPV and Either High-Dose or Standard Inactivated Polio Vaccine.
    Brickley EB; Strauch CB; Wieland-Alter WF; Connor RI; Lin S; Weiner JA; Ackerman ME; Arita M; Oberste MS; Weldon WC; Sáez-Llorens X; Bandyopadhyay AS; Wright PF
    J Infect Dis; 2018 Jan; 217(3):371-380. PubMed ID: 29304199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Megakaryocytes and platelets in immune thrombocytopenic purpura.
    Wang ZY; Shen ZX
    Baillieres Clin Haematol; 1997 Feb; 10(1):89-107. PubMed ID: 9154317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Prevots DR; Burr RK; Sutter RW; Murphy TV;
    MMWR Recomm Rep; 2000 May; 49(RR-5):1-22; quiz CE1-7. PubMed ID: 15580728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diarrhea as a minor adverse effect due to oral polio vaccine.
    Sugawara T; Ohsuka Y; Taya K; Yasui Y; Wada N; Sakano M; Koshida R; Fujii F; Shibata S; Hashimoto G; Utsumi H; Sumitomo M; Ishihara M; Kondo H; Sato H; Ueno K; Araki K; Okabe N
    Jpn J Infect Dis; 2009 Jan; 62(1):51-3. PubMed ID: 19168959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protocol Paper: Oral Poliovirus Vaccine Transmissibility in Communities After Cessation of Routine Oral Poliovirus Vaccine Immunization.
    Sarnquist C; Holubar M; García-García L; Ferreyra-Reyes L; Delgado-Sánchez G; Cruz-Hervert LP; Montero-Campos R; Altamirano J; Purington N; Boyle S; Modlin J; Ferreira-Guerrero E; Canizales-Quintero S; Díaz Ortega JL; Desai M; Maldonado YA
    Clin Infect Dis; 2018 Oct; 67(suppl_1):S115-S120. PubMed ID: 30376084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary and booster vaccination with an inactivated poliovirus vaccine (IPV) is immunogenic and well-tolerated in infants and toddlers in China.
    Li R; Li CG; Li Y; Liu Y; Zhao H; Chen X; Kuriyakose S; Van Der Meeren O; Hardt K; Hezareh M; Roy-Ghanta S
    Vaccine; 2016 Mar; 34(12):1436-43. PubMed ID: 26873055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polio eradication: the OPV paradox.
    Dowdle WR; De Gourville E; Kew OM; Pallansch MA; Wood DJ
    Rev Med Virol; 2003; 13(5):277-91. PubMed ID: 12931339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter study of the treatment of childhood chronic idiopathic thrombocytopenic purpura with anti-D.
    Andrew M; Blanchette VS; Adams M; Ali K; Barnard D; Chan KW; DeVeber LB; Esseltine D; Israels S; Korbrinsky N
    J Pediatr; 1992 Apr; 120(4 Pt 1):522-7. PubMed ID: 1313096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine administration and the development of immune thrombocytopenic purpura in children.
    Cecinati V; Principi N; Brescia L; Giordano P; Esposito S
    Hum Vaccin Immunother; 2013 May; 9(5):1158-62. PubMed ID: 23324619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.